AU658187B2 - Human bone derived insulin like growth factor binding protein - Google Patents

Human bone derived insulin like growth factor binding protein Download PDF

Info

Publication number
AU658187B2
AU658187B2 AU17844/92A AU1784492A AU658187B2 AU 658187 B2 AU658187 B2 AU 658187B2 AU 17844/92 A AU17844/92 A AU 17844/92A AU 1784492 A AU1784492 A AU 1784492A AU 658187 B2 AU658187 B2 AU 658187B2
Authority
AU
Australia
Prior art keywords
igfbp
hbd
igf
binds
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17844/92A
Other languages
English (en)
Other versions
AU1784492A (en
Inventor
David J. Baylink
Subburaman Mohan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU1784492A publication Critical patent/AU1784492A/en
Application granted granted Critical
Publication of AU658187B2 publication Critical patent/AU658187B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU17844/92A 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein Ceased AU658187B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19
US688353 1991-04-19
PCT/US1992/003122 WO1992018154A1 (en) 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein

Publications (2)

Publication Number Publication Date
AU1784492A AU1784492A (en) 1992-11-17
AU658187B2 true AU658187B2 (en) 1995-04-06

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17844/92A Ceased AU658187B2 (en) 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein

Country Status (11)

Country Link
EP (1) EP0580752A4 (de)
JP (1) JP2527896B2 (de)
KR (1) KR0129864B1 (de)
AU (1) AU658187B2 (de)
CA (1) CA2107475A1 (de)
CZ (1) CZ283601B6 (de)
FI (1) FI934588A (de)
HU (1) HUT70297A (de)
NO (1) NO933742L (de)
RU (1) RU2114120C1 (de)
WO (1) WO1992018154A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233155T2 (de) 1991-01-08 2004-06-03 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Insulinartigen wachstumsfaktor bindendes protein
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
EP0800530A4 (de) * 1994-07-20 1998-12-02 Celtrix Pharma Igf/igfbp-komplex zur förderung der knochenentwicklung und zur regulation des knochenumbaus
DE69637332T2 (de) 1995-10-11 2008-10-09 Novartis Vaccines and Diagnostics, Inc., Emeryville Kombinierung von PDGF, KGF, IGF und IGFBP für Wundheilung
PL228041B1 (pl) 2001-01-05 2018-02-28 Amgen Fremont Inc Przeciwciało przeciwko receptorowi insulinopodobnego czynnika wzrostu I, zawierajaca go kompozycja farmaceutyczna, sposób jego wytwarzania, zastosowania, linia komórkowa, wyizolowana czasteczka kwasu nukleinowego, wektor, komórka gospodarza oraz zwierze transgeniczne.
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network
EP3397644A4 (de) * 2015-12-31 2018-12-19 Siemens Healthcare Diagnostics Inc. Nicht-rekombinantes humanes insulin-like-wachstumsfaktorbindendes proteinkonzentrat

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028434A1 (de) * 1979-10-30 1981-05-13 Jacques Adriaan De Wijn Handwagen, Fahrgestell mit abklappbaren Rädern
US4642120A (en) * 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289314B1 (de) * 1987-04-28 1994-10-12 Roche Diagnostics GmbH Verwendung von IGF-II zur Behandlung von Knochenkrankheiten

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028434A1 (de) * 1979-10-30 1981-05-13 Jacques Adriaan De Wijn Handwagen, Fahrgestell mit abklappbaren Rädern
US4642120A (en) * 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones

Also Published As

Publication number Publication date
CA2107475A1 (en) 1992-10-20
FI934588A0 (fi) 1993-10-18
RU2114120C1 (ru) 1998-06-27
JPH06501270A (ja) 1994-02-10
NO933742L (no) 1993-10-18
CZ219093A3 (en) 1994-12-15
AU1784492A (en) 1992-11-17
JP2527896B2 (ja) 1996-08-28
WO1992018154A1 (en) 1992-10-29
HU9302942D0 (en) 1994-01-28
HUT70297A (en) 1995-09-28
EP0580752A1 (de) 1994-02-02
EP0580752A4 (en) 1994-08-24
KR0129864B1 (en) 1998-04-09
FI934588A (fi) 1993-10-18
CZ283601B6 (cs) 1998-05-13

Similar Documents

Publication Publication Date Title
US5736511A (en) Methods for treatment using acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5747452A (en) Method of modulating tumor cell migration using fibronectin type III peptides
EP0775742A2 (de) Inhibierung von TGF-beta zur Verhinderung von extrazellulärer Matrixanhäufung
JP2648951B2 (ja) 人体のソマトメジン担体蛋白質サブユニットとこれらの製法
EP0559769B1 (de) Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf)
JP3178714B2 (ja) インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
EP0546110B1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
Perkel et al. An inhibitory insulin-like growth factor binding protein (In-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived In-IGFBP
AU658187B2 (en) Human bone derived insulin like growth factor binding protein
EP0546074B1 (de) Genetisches igfbp-5 rodierendes material
US5453489A (en) Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
EP2252314B1 (de) Leptin-agonist und anwendungsverfahren
Gysen et al. Radioimmunoassay of proteoglycans
US5919902A (en) Leptin bound to inter-alphatrypsin inhibitor and uses thereof
JPH11506337A (ja) 骨刺激因子
IE913032A1 (en) New insulin-like growth factor binding protein (igfbp-4)
WO1999049894A1 (en) Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders
WO1994025057A1 (en) Kgf receptor-derived antagonists of kgf binding
US5693754A (en) Inhibitory binding protein for insulin-like growth factors
AU638935B2 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf)binding protein complex
US6329500B1 (en) Transforming growth factor-β binding site
US6465423B1 (en) Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US20030027753A1 (en) Bone stimulating factor
MXPA97009618A (en) Hue stimulating factors

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired